Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin vs Fibrovein in Venous Malformations
NCT01347294Phase 4Unknown
- Sponsor
- Oslo University Hospital
- Start
- Aug 2011
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bleomycin, sodium tetradecyl sulfate in venous malformation (VM), sponsored by Oslo University Hospital. Status: unknown.
02
Drugs
bleomycinsodium tetradecyl sulfate
03
Conditions
venous malformation (VM)
Beyond the preview
Go deeper on NCT01347294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01347294.